Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding.

Burke, T R; Nomizu, M; Otaka, A; Smyth, M S; Roller, P P; Case, R D; Wolf, G; Shoelson, S E

Burke, T R; Nomizu, M; Otaka, A; Smyth, M S; Roller, P P; Case, R D; Wolf, G; Shoelson, S E.

Affiliation

Burke TR; Laboratory of Medicinal Chemistry, NCI, National Institutes of Health, Bethesda, MD 20892.

Biochem Biophys Res Commun ; 201(3): 1148-53, 1994 Jun 30.

Article in En | MEDLINE | ID: mdl-8024556

Subject(s)

Peptides, Cyclic/pharmacology; Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors; Amino Acid Sequence; Molecular Sequence Data; Oligopeptides/chemistry; Oligopeptides/metabolism; Peptides, Cyclic/chemistry; Peptides, Cyclic/metabolism; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor)/metabolism; Structure-Activity Relationship

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Phosphotransferases (Alcohol Group Acceptor) Language: En Journal: Biochem Biophys Res Commun Year: 1994 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links